Susquehanna International Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.2M | Buy |
234,271
+164,869
| +238% | +$10.7M | ﹤0.01% | 2716 |
|
|
2025
Q4 | $5.56M | Buy |
69,402
+33,589
| +94% | +$2.26M | ﹤0.01% | 3848 |
|
|
2025
Q3 | $1.75M | Sell |
35,813
-31,014
| -46% | -$1.92M | ﹤0.01% | 6081 |
|
|
2025
Q2 | $4.99M | Buy |
66,827
+7,394
| +12% | +$490K | ﹤0.01% | 3971 |
|
|
2025
Q1 | $3.78M | Buy |
59,433
+37,429
| +170% | +$2.55M | ﹤0.01% | 4193 |
|
|
2024
Q4 | $1.72M | Buy |
+22,004
| New | +$1.77M | ﹤0.01% | 5656 |
|
|
2024
Q3 | – | Sell |
-13,583
| Closed | -$1.1M | – | 12395 |
|
|
2024
Q2 | $1.12M | Sell |
13,583
-1,121
| -8% | -$98.6K | ﹤0.01% | 6312 |
|
|
2024
Q1 | $1.25M | Sell |
14,704
-24,396
| -62% | -$1.91M | ﹤0.01% | 6357 |
|
|
2023
Q4 | $3.34M | Buy |
39,100
+7,333
| +23% | +$634K | ﹤0.01% | 4392 |
|
|
2023
Q3 | $2.85M | Buy |
31,767
+15,586
| +96% | +$1.39M | ﹤0.01% | 4474 |
|
|
2023
Q2 | $1.38M | Sell |
16,181
-5,712
| -26% | -$483K | ﹤0.01% | 5954 |
|
|
2023
Q1 | $1.81M | Buy |
21,893
+9,536
| +77% | +$772K | ﹤0.01% | 5354 |
|
|
2022
Q4 | $972K | Sell |
12,357
-27,307
| -69% | -$2.19M | ﹤0.01% | 6256 |
|
|
2022
Q3 | $2.94M | Buy |
39,664
+29,328
| +284% | +$2.11M | ﹤0.01% | 4144 |
|
|
2022
Q2 | $674K | Buy |
10,336
+2,539
| +33% | +$150K | ﹤0.01% | 7528 |
|
|
2022
Q1 | $493K | Sell |
7,797
-27,234
| -78% | -$1.48M | ﹤0.01% | 9022 |
|
|
2021
Q4 | $1.86M | Sell |
35,031
-15,199
| -30% | -$926K | ﹤0.01% | 5683 |
|
|
2021
Q3 | $3.55M | Sell |
50,230
-32,508
| -39% | -$2.05M | ﹤0.01% | 4601 |
|
|
2021
Q2 | $5.51M | Buy |
82,738
+76,138
| +1,154% | +$5.39M | ﹤0.01% | 3868 |
|
|
2021
Q1 | $733K | Buy |
6,600
+1,238
| +23% | +$153K | ﹤0.01% | 8539 |
|
|
2020
Q4 | $637K | Sell |
5,362
-23,440
| -81% | -$2.52M | ﹤0.01% | 7753 |
|
|
2020
Q3 | $2.51M | Sell |
28,802
-9,667
| -25% | -$845K | ﹤0.01% | 4181 |
|
|
2020
Q2 | $3.44M | Buy |
38,469
+23,491
| +157% | +$2.37M | ﹤0.01% | 3573 |
|
|
2020
Q1 | $1.49M | Buy |
14,978
+9,054
| +153% | +$982K | ﹤0.01% | 4506 |
|
|
2019
Q4 | $681K | Sell |
5,924
-19,536
| -77% | -$2.36M | ﹤0.01% | 6312 |
|
|
2019
Q3 | $3.21M | Buy |
25,460
+5,319
| +26% | +$675K | ﹤0.01% | 3384 |
|
|
2019
Q2 | $2.42M | Buy |
+20,141
| New | +$1.98M | ﹤0.01% | 3802 |
|
|
2019
Q1 | – | Sell |
-4,049
| Closed | -$368K | – | 9235 |
|
|
2018
Q4 | $405K | Buy |
+4,049
| New | +$425K | ﹤0.01% | 6424 |
|
|
2018
Q3 | – | Sell |
-32,310
| Closed | -$3.34M | – | 9607 |
|
|
2018
Q2 | $2.9M | Buy |
+32,310
| New | +$2.73M | ﹤0.01% | 3434 |
|
|
2018
Q1 | – | Sell |
-4,059
| Closed | -$278K | – | 9645 |
|
|
2017
Q4 | $236K | Buy |
+4,059
| New | +$214K | ﹤0.01% | 7974 |
|
|
2017
Q3 | – | Sell |
-11,260
| Closed | -$445K | – | 9124 |
|
|
2017
Q2 | $445K | Buy |
+11,260
| New | +$462K | ﹤0.01% | 6859 |
|
|
2017
Q1 | – | Sell |
-78,842
| Closed | -$3.17M | – | 9325 |
|
|
2016
Q4 | $3.17M | Buy |
+78,842
| New | +$2.97M | ﹤0.01% | 3132 |
|
|
2016
Q1 | – | Sell |
-6,642
| Closed | -$214K | – | 9264 |
|
|
2015
Q4 | $214K | Sell |
6,642
-2,664
| -29% | -$86.4K | ﹤0.01% | 8310 |
|
|
2015
Q3 | $301K | Sell |
9,306
-42,689
| -82% | -$1.61M | ﹤0.01% | 8032 |
|
|
2015
Q2 | $2.15M | Buy |
51,995
+18,179
| +54% | +$766K | ﹤0.01% | 4565 |
|
|
2015
Q1 | $1.52M | Buy |
33,816
+8,538
| +34% | +$357K | ﹤0.01% | 4890 |
|
|
2014
Q4 | $945K | Buy |
+25,278
| New | +$926K | ﹤0.01% | 5982 |
|
|
2014
Q3 | – | Sell |
-24,992
| Closed | -$882K | – | 9623 |
|
|
2014
Q2 | $882K | Buy |
24,992
+14,607
| +141% | +$488K | ﹤0.01% | 6312 |
|
|
2014
Q1 | $338K | Sell |
10,385
-9,165
| -47% | -$350K | ﹤0.01% | 7408 |
|
|
2013
Q4 | $824K | Buy |
19,550
+13,901
| +246% | +$572K | ﹤0.01% | 5835 |
|
|
2013
Q3 | $225K | Buy |
+5,649
| New | +$237K | ﹤0.01% | 7598 |
|
Other funds holding HAE
VPM
VCM
RRAM
Susquehanna International Group's HAE Position: Q1 2026 in Review
Susquehanna International Group increased its Haemonetics (HAE) stake by 238% in Q1 2026, buying an estimated $10.7M and bringing the position to 234,271 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2716.
Susquehanna International Group first reported a position in HAE in Q3 2013 and has held it in 41 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Susquehanna International Group held 234,271 shares of Haemonetics worth $13.2M as of Q1 2026.
- Susquehanna International Group bought 164,869 Haemonetics shares in Q1 2026, an estimated $10.7M.
- Haemonetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2716 holding.
- Susquehanna International Group first reported a position in Haemonetics in Q3 2013 and has held it in 41 quarters since.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.